CN101337971B - 一种抗菌素盐酸头孢吡肟的合成方法 - Google Patents
一种抗菌素盐酸头孢吡肟的合成方法 Download PDFInfo
- Publication number
- CN101337971B CN101337971B CN2008100225423A CN200810022542A CN101337971B CN 101337971 B CN101337971 B CN 101337971B CN 2008100225423 A CN2008100225423 A CN 2008100225423A CN 200810022542 A CN200810022542 A CN 200810022542A CN 101337971 B CN101337971 B CN 101337971B
- Authority
- CN
- China
- Prior art keywords
- mpca
- charging capacity
- aca
- add
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- LRAJHPGSGBRUJN-OMIVUECESA-N cefepime hydrochloride Chemical compound O.Cl.[Cl-].S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 LRAJHPGSGBRUJN-OMIVUECESA-N 0.000 title claims abstract 5
- 229960000927 cefepime hydrochloride Drugs 0.000 title claims description 23
- 230000003115 biocidal effect Effects 0.000 title claims description 5
- 230000002194 synthesizing effect Effects 0.000 title description 4
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 claims abstract description 43
- 238000006243 chemical reaction Methods 0.000 claims abstract description 41
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 claims abstract description 33
- 150000002148 esters Chemical class 0.000 claims abstract description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 62
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 42
- 239000000243 solution Substances 0.000 claims description 34
- 238000003756 stirring Methods 0.000 claims description 32
- 239000008367 deionised water Substances 0.000 claims description 31
- 229910021641 deionized water Inorganic materials 0.000 claims description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 22
- 239000003960 organic solvent Substances 0.000 claims description 21
- 238000005406 washing Methods 0.000 claims description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- 239000012065 filter cake Substances 0.000 claims description 12
- 239000012074 organic phase Substances 0.000 claims description 12
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 10
- 238000001291 vacuum drying Methods 0.000 claims description 9
- 239000013078 crystal Substances 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 6
- 238000010189 synthetic method Methods 0.000 claims description 6
- NEXSMEBSBIABKL-UHFFFAOYSA-N hexamethyldisilane Chemical compound C[Si](C)(C)[Si](C)(C)C NEXSMEBSBIABKL-UHFFFAOYSA-N 0.000 claims description 5
- 230000000630 rising effect Effects 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- -1 hexamethyldisilane amine Chemical class 0.000 abstract description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 238000001308 synthesis method Methods 0.000 abstract 2
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 abstract 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 1
- 241001515965 unidentified phage Species 0.000 abstract 1
- MMRINLZOZVAPDZ-LSGRDSQZSA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride Chemical compound Cl.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 MMRINLZOZVAPDZ-LSGRDSQZSA-N 0.000 description 48
- 229960002100 cefepime Drugs 0.000 description 29
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 238000005917 acylation reaction Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000009776 industrial production Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000000638 solvent extraction Methods 0.000 description 4
- 239000003513 alkali Substances 0.000 description 3
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 3
- 235000015320 potassium carbonate Nutrition 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- KFCMZNUGNLCSJQ-NFBKMPQASA-N (4-methoxyphenyl)methyl (6r,7r)-3-(chloromethyl)-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)C1=C(CCl)CS[C@H]2N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1 KFCMZNUGNLCSJQ-NFBKMPQASA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100225423A CN101337971B (zh) | 2008-08-15 | 2008-08-15 | 一种抗菌素盐酸头孢吡肟的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100225423A CN101337971B (zh) | 2008-08-15 | 2008-08-15 | 一种抗菌素盐酸头孢吡肟的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101337971A CN101337971A (zh) | 2009-01-07 |
CN101337971B true CN101337971B (zh) | 2011-01-26 |
Family
ID=40212151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100225423A Expired - Fee Related CN101337971B (zh) | 2008-08-15 | 2008-08-15 | 一种抗菌素盐酸头孢吡肟的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101337971B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010083725A1 (zh) * | 2009-01-20 | 2010-07-29 | 山东轩竹医药科技有限公司 | 含有取代的含氮稠杂环的头孢菌素衍生物 |
CN101935325B (zh) * | 2010-09-19 | 2012-02-08 | 海南新中正制药有限公司 | 盐酸头孢吡肟的制备方法 |
CN102276631A (zh) * | 2011-06-16 | 2011-12-14 | 哈药集团制药总厂 | 一种盐酸头孢吡肟的制备方法 |
CN103044454B (zh) * | 2011-10-14 | 2016-04-13 | 四川科伦药业股份有限公司 | 一种硫酸头孢噻利的合成方法 |
CN102408440A (zh) * | 2011-12-27 | 2012-04-11 | 山东鑫泉医药有限公司 | 盐酸头孢吡肟的合成方法 |
CN102675345A (zh) * | 2012-06-01 | 2012-09-19 | 苏州中联化学制药有限公司 | 一种盐酸头孢吡肟的制备方法 |
CN108503656A (zh) * | 2017-02-28 | 2018-09-07 | 江苏恒安化工有限公司 | 一种盐酸头孢吡肟中间体的合成方法 |
CN109776572B (zh) * | 2019-01-23 | 2020-11-10 | 华北制药河北华民药业有限责任公司 | 一种盐酸头孢吡肟的纯化方法 |
-
2008
- 2008-08-15 CN CN2008100225423A patent/CN101337971B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101337971A (zh) | 2009-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101337971B (zh) | 一种抗菌素盐酸头孢吡肟的合成方法 | |
CN105131017B (zh) | 一种盐酸头孢卡品酯的制备方法 | |
CN103467495A (zh) | 一种头孢克肟化合物的制备方法 | |
CN101235045A (zh) | 头孢西丁钠的制备方法 | |
CN101619069A (zh) | 一种头孢替安酯盐酸盐的制备方法 | |
CN102617607A (zh) | 一种制备头孢唑啉化合物的方法 | |
CN105037393A (zh) | 一种氟氧头孢钠的制备方法 | |
CN105254648B (zh) | 一种头孢维星及其钠盐的合成方法 | |
CN104193765B (zh) | 一种头孢克肟的合成方法 | |
CN101210019A (zh) | 甲氧基头孢菌素中间体 | |
CN102219794A (zh) | 一种头孢唑肟钠的制备方法 | |
CN101337970B (zh) | 一种抗菌素硫酸头孢匹罗的合成方法 | |
RU2711358C1 (ru) | Простой способ получения авибактама | |
US20040092735A1 (en) | Process for the preparation of cefuroxime sodium | |
CN101550150B (zh) | 一种头孢甲肟化合物及其合成方法 | |
CN104130272A (zh) | 一种头孢氨苄合成工艺改进方法 | |
CN104277053A (zh) | 一种高纯度头孢地嗪及其中间体头孢地嗪酸的制备方法 | |
CN1958591B (zh) | 头孢菌素类中间体的制备方法及头孢唑肟丙匹酯的制备方法 | |
CN102010432B (zh) | 一种头孢地嗪钠化合物及其新方法 | |
CN104230956B (zh) | 一种头孢西丁的制备方法 | |
CN113025679B (zh) | 一种叔丁氧羰基头孢卡品前体酸的酶法制备工艺 | |
CN102898443B (zh) | 高收率超净高纯化头孢地嗪钠的精制方法 | |
CN105017287B (zh) | 一种头霉素中间体的制备方法 | |
CN108084212A (zh) | 一种头孢妥仑匹酯的制备方法 | |
CN101607965A (zh) | 一种制备头孢匹胺钠的新工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SINOPHARM GROUP ZHIJUN (SUZHOU) PHARMACEUTICAL CO. Free format text: FORMER NAME: SUZHOU ZHIJUN WANQING PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 215415 Taicang Regal Economic Development Zone, Jiangsu Patentee after: SINOPHARM ZHIJUN (SUZHOU) PHARMACEUTICAL CO.,LTD. Address before: 215415 Taicang Regal Economic Development Zone, Jiangsu Patentee before: SUZHOU ZHIJUN WANQING PHARMACEUTICAL Co.,Ltd. |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20200410 Granted publication date: 20110126 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230410 Granted publication date: 20110126 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110126 |